Erythropoietin: all 97 studies that test it

Page 1 of 1. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.

• Probiotics Against Erythropoietin Resistance in Chronic Kidney Disease Patients.Not yet recruitingNCT07296146Phase 3
• Xenograft with or Without Erythropoietin in Immediate Dental ImplantNot yet recruitingNCT06601400Not applicable
• Erythropoietin in HIE NeonateNot yet recruitingNCT06590155Early Phase 1
• PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG)RecruitingNCT06542393Phase 2
• Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in ChildrensNot yet recruitingNCT05704894Phase 3
• Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial)RecruitingNCT05395195Phase 3
• Practical Anemia Bundle for SusTained Blood RecoveryCompletedNCT05167734Phase 2Results posted
• Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe)CompletedNCT03457701Phase 2Results posted
• Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of ErythropoietinTerminatedNCT03277183Phase 4Results posted
• The Prevention of Erythropoietin on Cardiac Surgery-associated Acute Kidney InjuryTerminatedNCT03007537Not applicableResults posted
• High-dose Erythropoietin for Asphyxia and EncephalopathyCompletedNCT02811263Phase 3Results posted
• Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)CompletedNCT01913340Phase 1/2Results posted
• Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on DialysisCompletedNCT01478971Phase 3Results posted
• Prevention of Acute Kidney Injury by Erythropoietin in Thoracic Aorta Surgery With Hypothermic Cardiac ArrestCompletedNCT01369732Phase 4Results posted
• Allogenic Umbilical Cord Blood and Erythropoietin Combination Therapy for Cerebral PalsyCompletedNCT01193660Not applicableResults posted
• Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM2)CompletedNCT01023035Phase 3Results posted
• Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical ProstatectomyCompletedNCT00737893Phase 2Results posted
• Nephropathy In Type 2 Diabetes and Cardio-renal EventsCompletedNCT00535925Phase 4Results posted
• Treatment of Myelodysplastic Syndrome (MDS) With Cytokine-Immunotherapy for Low-Risk MDSCompletedNCT00520468Phase 2Results posted
• Azacitidine and Erythropoietin Versus Azacitidine Alone for Patients With Low-Risk Myelodysplastic SyndromesTerminatedNCT00379912Phase 2Results posted
• Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic SyndromesCompletedNCT00003138Phase 3Results posted
• EPO for Postop Delirium in Elderly PatientsCompletedNCT06178835Phase 4
• Topical Erythropoietin Hydrogel in Management of Oral Lichen PlanusStatus unknownNCT06135259Phase 3
• Tracing Changed Production of Red Blood CellsCompletedNCT05833477Not applicable
• Colorado-Oregon Altitude StudyCompletedNCT05734716Phase 4
• Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant RecipientsActive, not recruitingNCT05325073Phase 4
• Pharmacological Countermeasures for High AltitudeActive, not recruitingNCT05300477Phase 4
• Erythropoietin to Improve Critical Care Patient OutcomesStatus unknownNCT05080049Phase 3
• Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in LymphomaStatus unknownNCT04910594Phase 3
• Subcutaneous Injection of Erythropoietin on Visual Functions in Patients With Late Onset Optic NeuropathyCompletedNCT04469777Phase 1/2
• Effect of Erythropoietin on Neurodevelopmental Outcomes in Very Preterm Infants With Intraventricular HemorrhageCompletedNCT03914690Phase 2
• Effect of Recombinant Human EPO on the Postoperative Neurologic Outcome in Pediatric Moyamoya PatientsActive, not recruitingNCT03882060Not applicable
• Use of Erythropoietin to Expand Regulatory T Cells in Autoimmune Liver DiseaseCompletedNCT03842254Early Phase 1
• Erythropoietin in Hemolytic Uremic SyndromeCompletedNCT03776851Phase 4
• NAION Treatment With Oral Prednisolone and Erythropoietin InjectionStatus unknownNCT03715881Phase 2
• Exosome Proteomics to Detect EPOStatus unknownNCT03700515Not applicable
• Erythropoietin Role in Acute Kidney InjuryTerminatedNCT03401710Not applicable
• Effects of Erythropoietin for Cognitive Side-effects of ECTCompletedNCT03339596Phase 2
• Effects of Erythropoietin on Cognition and Neural Activity in Mood DisordersCompletedNCT03315897Phase 2
• Traumatic Optic Neuropathy Treatment Trial 2CompletedNCT03308448Phase 3
• Erythropoietin in Management of Neonatal Hypoxic Ischemic EncephalopathyStatus unknownNCT03163589Phase 3
• Multiple Burrhole Therapy With Erythropoietin for Unstable MoyamoyaCompletedNCT03162588Phase 1/2
• The Effect of Human Recombinant Erythropoietin in Acute Renal FailureCompletedNCT03102021Phase 2
• Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell TransplantationStatus unknownNCT03010579Phase 4
• Effect of Erythropoietin in Refractory Autoimmune Encephalitis PatientsWithdrawnNCT03004209Phase 4
• Erythropoietin Effect on Ischemic_ Reperfusion Injury in Coronary Artery Bypass Graft SurgeryCompletedNCT02984111Not applicable
• Recombinant Human Erythropoietin Improve Neurodevelopmental Outcomes in Extremely Preterm InfantsStatus unknownNCT02745990Not applicable
• Neovascularization Induced by Mechanical Barrier disrUption and Systemic Erythropoietin in Patients With Cerebral Perfusion DeficitsCompletedNCT02603406Phase 2
• Erythropoietin + Iron Therapy for Anemic Patients Undergoing Aortic Valve ReplacementCompletedNCT02390102Phase 3
• Erythropoietin in Methanol Associated Optic Neuropathy: A Phase-2 Clinical Trial (EPO-MAON Study)Status unknownNCT02376881Phase 3
• Effect of Recombinant Erythropoietin on Numbers of Circulating Endothelial Progenitor Cells in People With Persistent Symptoms During the Subacute Period After Traumatic Brain InjuryWithdrawnNCT02226848Phase 2
• Effect of Recombinant Erythropoietin on Numbers of Circulating Endothelial Progenitor Cells in Subacute TBIWithdrawnNCT02148367Phase 2
• Erythropoietin for the Repair of Cerebral Injury in Very Preterm InfantsStatus unknownNCT02076373Phase 3
• Effect of Erythropoietin on Preterm Brain InjuryCompletedNCT02036073Phase 4
• Impact of Preoperative Treatment of Anemia and Iron Deficiency in Cardiac Surgery on Outcome.CompletedNCT02031289Phase 4
• Neuroprotective Role of Erythropoietin in Perinatal AsphyxiaCompletedNCT02002039Phase 2/3
• Non-erythroid Effects of Erythropoietin on Cognitive Function and Exercise Capacity in HumansStatus unknownNCT01889056Phase 1/2
• Erythropoietin in the Prevention of Acute Mountain SicknessCompletedNCT01665781Phase 4
• Erythropoietin Therapy for Children With Cerebral PalsyCompletedNCT01650415Phase 2
• Erythropoietin Therapy for Children With Cerebral Palsy: Phase 1CompletedNCT01586052Phase 1
• Renal Effects of Erythropoietin in HumansCompletedNCT01584921Phase 1
• Erythropoietin and Platelet Activation MarkersCompletedNCT01392612Phase 4
• Identification of New Serum Markers for Detection of Abuse With ErythropoietinCompletedNCT01320449Not applicable
• Blood Sparing Strategies: Single Shot High Dose Erythropoietin Two Days Before Heart SurgeryCompletedNCT01265680Not applicable
• The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Very Low Birth Weight InfantsCompletedNCT01203514Phase 2/3
• Efficacy of Ferric Carboxymaltose With or Without EPO Reducing Red-cell Transfusion Packs in Hip Fracture Perioperative PeriodCompletedNCT01154491Phase 3
• The Effects of Erythropoietin on Clinical Disability and Brain Pathology in Patients With Progressive Multiple SclerosisStatus unknownNCT01144117Phase 2
• Blood Management in Orthopedic SurgeryCompletedNCT00998088Phase 4
• Effect of Preoperative Recombinant Human Erythropoietin on Transfusion Risk in Valvular Heart SurgeryCompletedNCT00939978Not applicable
• Effects of Erythropoietin on Depressive Symptoms and Neurocognitive Deficits in Depression and Bipolar DisorderCompletedNCT00916552Phase 2
• Neurological Outcome After Erythropoietin Treatment for Neonatal EncephalopathyCompletedNCT00808704Phase 1/2
• Insulin Resistance and Substrate Metabolism After Acute Erythropoietin (EPO) AdministrationCompletedNCT00793767Not applicable
• Neonatal Erythropoietin in Asphyxiated Term NewbornsCompletedNCT00719407Phase 1
• Randomized Trial of Erythropoietin During Cerebral MalariaStatus unknownNCT00697164Phase 2/3
• Effects of Intravenous Injection of Erythropoietin on Hepcidin Pharmacokinetics in Healthy VolunteersCompletedNCT00687518Not applicable
• Relationship Between Erythropoietin Administration and Stress Responses in Trauma PatientsStatus unknownNCT00622934Phase 2
• The Effect of Erythropoietin Usage in Renal Function After Kidney Transplantation, in Early Phase, in Contrast to Placebo GroupStatus unknownNCT00617474Phase 1
• High-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II StudyTerminatedNCT00589953Phase 2
• A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease PatientsCompletedNCT00563355Not applicable
• Evaluation of Tolerability and Efficacy of Erythropoietin (EPO) Treatment in Spinal Shock: Comparative Study Versus Methylprednisolone (MP)TerminatedNCT00561067Phase 3
• Erythropoietin for Infants With Brain Injuries Due to Oxygen Deprivation at BirthStatus unknownNCT00491413Phase 1
• Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic AcidStatus unknownNCT00437450Phase 2
• Anti-Restenosis After AMI by ErythropoietinStatus unknownNCT00423020Phase 4
• Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal FunctionStatus unknownNCT00418119Phase 4
• Does Erythropoietin Improve Outcome in Very Preterm Infants?CompletedNCT00413946Phase 2
• Efficacy Study of Erythropoietin After Revascularization in Myocardial Infarction (REVIVAL-3)CompletedNCT00390832Phase 3
• Safety and Efficacy Study of Erythropoietin as add-on Therapy of Methylprednisolone to Treat Acute Optic NeuritisCompletedNCT00355095Phase 2
• Impact of Erythropoietin Administration During Definitive Cervix Cancer Radiotherapy on Treatment OutcomeStatus unknownNCT00348738Phase 3
• Comparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy TrialCompletedNCT00322413Phase 3
• REPEAT Study - Resistance to ErythroPoietin Effectiveness Algorithm TrialTerminatedNCT00319150Phase 3
• Hydroxyurea and Erythropoietin to Treat Sickle Cell AnemiaCompletedNCT00270478Phase 1
• Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on DialysisCompletedNCT00236964Phase 3
• Erythropoietin Spinal Cord Compression Randomized TrialTerminatedNCT00220675Phase 2/3
• Erythropoietin in Acute Myocardial InfarctionStatus unknownNCT00149058Phase 2
• A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing ChemotherapyCompletedNCT00144495Phase 3
• A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing ChemotherapyCompletedNCT00144482Phase 3
• Treatment for Patients Suffering From Anemia Due to ChemotherapyCompletedNCT00120692Phase 2

← Erythropoietin overview